Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Asset disposition
Quarterly results
Director departure
Appointed director
CC transcript
Credit agrmnt [a]
ABBOTT LABORATORIES (ABT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/27/2023 144 Form 144 - Report of proposed sale of securities:
07/26/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 8-K Quarterly results
06/16/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/09/2023 8-K/A Submission of Matters to a Vote of Security Holders  Interactive Data
05/31/2023 SD Form SD - Specialized disclosure report:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/03/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
05/02/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 144 Form 144 - Report of proposed sale of securities:
05/02/2023 8-K Quarterly results
04/19/2023 8-K Quarterly results
03/17/2023 ARS Form ARS - Annual Report to Security Holders:
03/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/17/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.9% stake in Abbott Laboratories
02/06/2023 SC 13G/A BlackRock Inc. reports a 8% stake in ABBOTT LABORATORIES
01/25/2023 8-K Quarterly results
Docs: "Abbott Reports Fourth-Quarter and Full-Year 2022"
12/09/2022 8-K Quarterly results
11/01/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/21/2022 8-K Quarterly results
10/19/2022 8-K Quarterly results
09/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "By-Laws of Abbott Laboratories, as amended and restated effective September 15, 2022"
08/02/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/20/2022 8-K Quarterly results
06/27/2022 11-K Form 11-K - Annual report of employee stock purchase, savings and similar plans:
05/27/2022 SD Form SD - Specialized disclosure report:
05/03/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/02/2022 8-K Quarterly results
04/20/2022 8-K Quarterly results
Docs: "Sales growth of 13.8 percent; organic sales growth of 17.5 percent"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy